Clinical Trials for Altimmune

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Altimmune

Clinical Trials (3)

NCT07009860
RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
PHASE2Recruiting
100 participants
Started: Jun 16, 2025 · Completed: Aug 31, 2027
1 condition1 sponsor35 locations
NCT06987513
RECLAIM STUDY: A Phase 2 Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight
PHASE2Recruiting
100 participants
Started: May 15, 2025 · Completed: Sep 30, 2026
1 condition1 sponsor12 locations
NCT05989711
IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)
PHASE2Active, not recruiting
190 participants
Started: Jul 27, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor40 locations